Novartis AG (SWX:NOVNEE)

Novartis AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	53,263	50,317	45,440	42,206	42,781	48,659
Other Revenue	1,923	1,405	1,220	1,255	1,193	1,239
Revenue	55,186	51,722	46,660	43,461	43,974	49,898
Revenue Growth (YoY)	12.95%	10.85%	7.36%	-1.17%	-11.87%	2.51%
Cost of Revenue	13,089	12,815	12,020	11,582	11,391	15,121
Gross Profit	42,097	38,907	34,640	31,879	32,583	34,777
Selling, General & Admin	13,131	12,564	12,489	12,193	12,756	14,197
Research & Development	9,709	9,511	9,011	9,172	8,259	8,980
Other Operating Expenses	76	512	498	1,301	605	1,448
Operating Expenses	22,916	22,587	21,998	22,666	21,620	24,625
Operating Income	19,181	16,320	12,642	9,213	10,963	10,152
Interest Expense	-1,098	-1,006	-855	-800	-787	-869
Interest & Investment Income	568	568	627	377	70	91
Earnings From Equity Investments	-13	-38	-13	-11	15,337	673
Currency Exchange Gain (Loss)	-258	-258	-214	-184	-69	-135
Other Non Operating Income (Expenses)	13	61	3	-14	-29	-34
EBT Excluding Unusual Items	18,393	15,647	12,190	8,581	25,485	9,878
Merger & Restructuring Charges	-364	-364	-951	-1,267	-827	-
Gain (Loss) on Sale of Investments	-46	-45	-105	-	38	-
Gain (Loss) on Sale of Assets	45	45	225	-	724	-
Asset Writedown	-1,522	-1,428	-3,088	-	-619	-
Legal Settlements	-202	-89	542	-	-170	-
Other Unusual Items	-696	-126	310	-137	-101	-
Pretax Income	15,608	13,640	9,123	7,177	24,530	9,878
Income Tax Expense	1,970	1,701	551	1,128	1,625	1,807
Earnings From Continuing Operations	13,638	11,939	8,572	6,049	22,905	8,071
Earnings From Discontinued Operations	-	-	6,282	906	1,113	-
Net Income to Company	13,638	11,939	14,854	6,955	24,018	8,071
Minority Interest in Earnings	16	2	-4	-	3	1
Net Income	13,654	11,941	14,850	6,955	24,021	8,072
Net Income to Common	13,654	11,941	14,850	6,955	24,021	8,072
Net Income Growth	-15.59%	-19.59%	113.52%	-71.05%	197.58%	-31.20%
Shares Outstanding (Basic)	1,978	2,018	2,077	2,181	2,243	2,277
Shares Outstanding (Diluted)	1,994	2,035	2,092	2,197	2,260	2,296
Shares Change (YoY)	-3.37%	-2.73%	-4.78%	-2.79%	-1.57%	-0.99%
EPS (Basic)	6.90	5.92	7.15	3.19	10.71	3.54
EPS (Diluted)	6.85	5.87	7.10	3.17	10.63	3.52
EPS Growth	-12.59%	-17.36%	123.90%	-70.16%	202.06%	-30.43%
Free Cash Flow	19,324	16,253	13,398	13,320	14,005	12,375
Free Cash Flow Per Share	9.69	7.99	6.40	6.06	6.20	5.39
Dividend Per Share	3.862	3.862	3.919	3.461	3.401	3.391
Dividend Growth	-1.44%	-1.44%	13.24%	1.77%	0.29%	8.68%
Gross Margin	76.28%	75.22%	74.24%	73.35%	74.10%	69.70%
Operating Margin	34.76%	31.55%	27.09%	21.20%	24.93%	20.35%
Profit Margin	24.74%	23.09%	31.83%	16.00%	54.63%	16.18%
Free Cash Flow Margin	35.02%	31.42%	28.71%	30.65%	31.85%	24.80%
EBITDA	23,642	20,662	17,518	13,940	15,633	14,932
EBITDA Margin	42.84%	39.95%	37.54%	32.07%	35.55%	29.93%
D&A For EBITDA	4,461	4,342	4,876	4,727	4,670	4,780
EBIT	19,181	16,320	12,642	9,213	10,963	10,152
EBIT Margin	34.76%	31.55%	27.09%	21.20%	24.93%	20.35%
Effective Tax Rate	12.62%	12.47%	6.04%	15.72%	6.63%	18.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.